Rabia Bibi

Investigating the mechanism of action underlying the ability of kappa opioid receptor agonists to promote oligodendrocyte differentiation and myelination in vitro

Multiple sclerosis (MS) is a demyelinating, autoimmune, neuroinflammatory disease that affects ~3 million people worldwide. In MS, the body’s immune system attacks the protective myelin coating surrounding nerve cells, impairing salutatory conduction. Unfortunately, there is no cure for MS, and due to the scarcity of e...